PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThe BMJ
 
BMJ. 1989 September 9; 299(6700): 663–665.
PMCID: PMC1837599

Sample size and power for comparing two or more treatment groups in clinical trials.

Abstract

Methods for determining sample size and power when comparing two groups in clinical trials are widely available. Studies comparing three or more treatments are not uncommon but are more difficult to analyse. A linear nomogram was devised to help calculate the sample size required when comparing up to five parallel groups. It may also be used retrospectively to determine the power of a study of given sample size. In two worked examples the nomogram was efficient. Although the nomogram offers only 5% and 1% significance levels and can be used only for up to five treatment groups, this is sufficient for most researchers.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (599K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Clark CJ, Downie CC. A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet. 1966 Dec 17;2(7477):1357–1358. [PubMed]
  • Miller DK, Homan SM. Graphical aid for determining power of clinical trials involving two groups. BMJ. 1988 Sep 10;297(6649):672–676. [PMC free article] [PubMed]
  • Lachin JM. Sample size determinants for r X c comparative trials. Biometrics. 1977 Jun;33(2):315–324. [PubMed]
  • Lucki I, Rickels K, Giesecke MA, Geller A. Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. Br J Clin Pharmacol. 1987 Feb;23(2):207–211. [PMC free article] [PubMed]
  • Banner NR, Lloyd MH, Hamilton RD, Innes JA, Guz A, Yacoub MH. Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation. Br Heart J. 1989 Mar;61(3):215–223. [PMC free article] [PubMed]
  • Rowbotham DJ, Nimmo WS. Effect of cisapride on morphine-induced delay in gastric emptying. Br J Anaesth. 1987 May;59(5):536–539. [PubMed]
  • Dodd P, Day SJ, Goldhill DR, MacLeod DM, Withington PS, Yate PM. Glycopyrronium requirements for antagonism of the muscarinic side effects of edrophonium. Br J Anaesth. 1989 Jan;62(1):77–81. [PubMed]
  • McHugh RB, Le CT. Confidence estimation and the size of a clinical trial. Control Clin Trials. 1984 Jun;5(2):157–163. [PubMed]
  • Day SJ. Clinical trial numbers and confidence intervals of pre-specified size. Lancet. 1988 Dec 17;2(8625):1427–1427. [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group